Telix Pharmaceuticals announced the establishment of Telix Japan, along with the appointment of the first two members of the Japanese leadership team.   Telix Japan is wholly-owned operating subsidiary of Telix Pharmaceuticals. The purpose of the subsidiary is to support Telix’s Japanese clinical and radiopharmaceutical manufacturing activities and to establish a commercial footprint in the Japan. Dr. Shintaro Nishimura has been appointed as president and chief operating officer, and Dr....